Healthcare provider profile · identity verified

Daniel Itano, D.O.

Family Practice · LAKE HAVASU CITY, AZ · NPI 1194133041

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	969	205
Eliquis	Apixaban	855	104
Gabapentin	Gabapentin	539	103
Levothyroxine Sodium	Levothyroxine Sodium	521	81
Amlodipine Besylate	Amlodipine Besylate	443	87
Furosemide	Furosemide	396	100
Donepezil Hcl	Donepezil Hcl	318	50
Lisinopril	Lisinopril	305	65
Tamsulosin Hcl	Tamsulosin Hcl	286	70
Losartan Potassium	Losartan Potassium	258	54
Memantine Hcl	Memantine Hcl	253	45
Metoprolol Succinate	Metoprolol Succinate	230	59
Clopidogrel	Clopidogrel Bisulfate	227	58
Potassium Chloride	Potassium Chloride	223	54
Metoprolol Tartrate	Metoprolol Tartrate	220	52
Sertraline Hcl	Sertraline Hcl	214	41
Metformin Hcl	Metformin Hcl	211	42
Hydralazine Hcl	Hydralazine Hcl	205	40
Carvedilol	Carvedilol	201	43
Mirtazapine	Mirtazapine	196	48
Levetiracetam	Levetiracetam	195	33
Famotidine	Famotidine	174	51
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	151	37
Finasteride	Finasteride	148	27
Januvia	Sitagliptin Phosphate	132	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	49
Baclofen	Baclofen	120	23
Midodrine Hcl	Midodrine Hcl	119	37
Divalproex Sodium	Divalproex Sodium	115	16
Trazodone Hcl	Trazodone Hcl	113	35
Xarelto	Rivaroxaban	111	16
Escitalopram Oxalate	Escitalopram Oxalate	106	23
Warfarin Sodium	Warfarin Sodium	105	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	102	49
Glipizide	Glipizide	101	24
Oxycodone Hcl	Oxycodone Hcl	101	51
Quetiapine Fumarate	Quetiapine Fumarate	97	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	92	19
Clonidine Hcl	Clonidine Hcl	90	39
Citalopram Hbr	Citalopram Hydrobromide	86	12
Amiodarone Hcl	Amiodarone Hcl	85	28
Oxybutynin Chloride Er	Oxybutynin Chloride	84	17
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	82	43
Topiramate	Topiramate	77	suppressed
Enulose	Lactulose	75	22
Ondansetron Hcl	Ondansetron Hcl	75	33
Buspirone Hcl	Buspirone Hcl	71	13
Allopurinol	Allopurinol	69	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	20
Hydroxyzine Hcl	Hydroxyzine Hcl	68	21
Insulin Lispro Kwikpen U-100	Insulin Lispro	61	15
Duloxetine Hcl	Duloxetine Hcl	59	14
Tizanidine Hcl	Tizanidine Hcl	55	11
Lamotrigine	Lamotrigine	54	suppressed
Meloxicam	Meloxicam	54	13
Albuterol Sulfate Hfa	Albuterol Sulfate	53	35
Cefdinir	Cefdinir	53	38
Tramadol Hcl	Tramadol Hcl	51	26
Pregabalin	Pregabalin	50	16
Montelukast Sodium	Montelukast Sodium	49	19
Alendronate Sodium	Alendronate Sodium	48	suppressed
Jardiance	Empagliflozin	48	suppressed
Prednisone	Prednisone	48	25
Celecoxib	Celecoxib	47	suppressed
Lactulose	Lactulose	47	26
Budesonide	Budesonide	43	18
Entresto	Sacubitril/Valsartan	42	suppressed
Simvastatin	Simvastatin	41	14
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Lacosamide	Lacosamide	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Lidocaine	Lidocaine	36	suppressed
Novolog Flexpen	Insulin Aspart	35	suppressed
Scopolamine	Scopolamine	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	11
Bupropion Xl	Bupropion Hcl	34	suppressed
Humalog Kwikpen U-100	Insulin Lispro	34	14
Myrbetriq	Mirabegron	34	suppressed
Insulin Aspart Flexpen	Insulin Aspart	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Albuterol Sulfate	Albuterol Sulfate	31	suppressed
Bumetanide	Bumetanide	31	suppressed
Megestrol Acetate	Megestrol Acetate	31	17
Torsemide	Torsemide	31	suppressed
Calcitriol	Calcitriol	30	suppressed
Humalog	Insulin Lispro	30	suppressed
Lubiprostone	Lubiprostone	30	suppressed
Primidone	Primidone	30	suppressed
Risperidone	Risperidone	30	11
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	30	13
Symbicort	Budesonide/Formoterol Fumarate	30	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	21
Nystop	Nystatin	29	16
Fluticasone Propionate	Fluticasone Propionate	28	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	14
Azithromycin	Azithromycin	27	22
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	13
Lidocaine Hcl Viscous	Lidocaine Hcl	27	suppressed
Brilinta	Ticagrelor	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	19
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	suppressed
Omeprazole	Omeprazole	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	15
Glipizide Er	Glipizide	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Methimazole	Methimazole	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	20
Nystatin	Nystatin	22	14
Rivastigmine	Rivastigmine Tartrate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Methocarbamol	Methocarbamol	21	16
Benztropine Mesylate	Benztropine Mesylate	20	suppressed
Cephalexin	Cephalexin	20	13
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Clonidine	Clonidine	20	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	20	12
Olanzapine	Olanzapine	20	suppressed
Sodium Chloride	0.9 % Sodium Chloride	20	14
Acetazolamide	Acetazolamide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Digoxin	Digoxin	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Bethanechol Chloride	Bethanechol Chloride	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Amoxicillin	Amoxicillin	14	11
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ozempic	Semaglutide	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Lorazepam	Lorazepam	13	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Entacapone	Entacapone	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error